Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review

YILMAZ TUĞAN B., ÖZKAN B., SÖNMEZ Ö.

SEMINARS IN OPHTHALMOLOGY, cilt.36, sa.8, ss.794-799, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 36 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/08820538.2021.1906916
  • Dergi Adı: SEMINARS IN OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.794-799
  • Anahtar Kelimeler: Metastatic malignant melanoma, nivolumab, serous retinal detachment, anterior uveitis, anti-PD-1 antibody
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Aim: Nivolumab is an immune checkpoint inhibitor that has recently been widely used for metastatic malignant melanoma. We report a case who developed multiple different ocular immune-related side effects (iRAEs) related to nivolumab.